Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization
Moran Sun, Yixin Zhang, Jinling Qin, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 104988-104988
Closed Access | Times Cited: 19

Showing 19 citing articles:

Natural products targeting tumour angiogenesis
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth
British Journal of Pharmacology (2023)
Open Access | Times Cited: 20
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
Christine Tran, Abdallah Hamzé
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 341-341
Open Access
Identification of 1,3,4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach
Agnidipta Das, Manaswini Sarangi, Kailash Jangid, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10323-10341
Closed Access | Times Cited: 12
2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response
Moran Sun, Jinling Qin, Yingying Kang, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105625-105625
Closed Access | Times Cited: 16
An overview on the exploring the interaction of inorganic nanoparticles with microtubules for the advancement of cancer therapeutics
Weidong Zhang, William C. Cho, Samir Haj Bloukh, et al.
International Journal of Biological Macromolecules (2022) Vol. 212, pp. 358-369
Open Access | Times Cited: 14
Zebrafish live imaging: a strong weapon in anticancer drug discovery and development
Tiancheng Zhan, Wanqian Song, Jing Guo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 8, pp. 1807-1835
Closed Access | Times Cited: 2
A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers
Zi Liu, Liancheng Huang, Tianhao Zhou, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 7, pp. 102063-102063
Open Access | Times Cited: 10
Structural Changes, Biological Consequences, and Repurposing of Colchicine Site Ligands
Felipe Montecinos-Franjola, Dan L. Sackett
Biomolecules (2023) Vol. 13, Iss. 5, pp. 834-834
Open Access | Times Cited: 5
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors
Moran Sun, Minghua Yuan, Yingying Kang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 339-354
Open Access | Times Cited: 9
Targeting an Old Foe for Cancer: A Molecular Dynamics Perspective to Unravel the Specific Binding Nature of 2-Methoxy Estradiol to Human β-Tubulin Isotypes
Sonia Kumari, M. Elizabeth Sobhia
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 4121-4133
Closed Access | Times Cited: 1
Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies
Wanlin Dai, Renhao Guo, Xinni Na, et al.
Redox Biology (2024) Vol. 73, pp. 103205-103205
Open Access | Times Cited: 1
Tubulin/HDAC dual-target inhibitors: Insights from design strategies, SARs, and therapeutic potential
Zhen Zhang, Rui Su, Juan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117022-117022
Closed Access | Times Cited: 1
Preparation of 2-Methoxyestradiol Self-emulsified Drug Delivery System and the Effect on Combination Therapy with Doxorubicin Against MCF-7/ADM Cells
Chuan Yu, Chen Li, Haofeng Pan, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 8
Angiogenesis, Anti-Tumor, and Anti-Metastatic Activity of Novel α-Substituted Hetero-Aromatic Chalcone Hybrids as Inhibitors of Microtubule Polymerization
Moran Sun, Yuyang Wang, Minghua Yuan, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 9
Alkaloids as Additional Weapons in the Fight against Breast Cancer: A review
Chahat, Keshav Taruneshwar Jha, Rohit Bhatia, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 32, pp. 5113-5148
Closed Access | Times Cited: 3
The role of HIF-1α/Bnip3/mitophagy in acrylonitrile-induced neuronal death in HT22 cells and mice: a potential neuroprotection target
Jing Hu, Bobo Yang, Zehua Tao, et al.
Chemico-Biological Interactions (2024) Vol. 406, pp. 111327-111327
Closed Access
2-Methoxyestradiol loaded mesoporous polydopamine nanoprobes for hypoxia alleviation and sorafenib synergistic treatment of hepatocellular carcinoma
Peifeng Wang, Yang Du, Xingyang Zhao, et al.
Materials & Design (2023) Vol. 232, pp. 112137-112137
Open Access | Times Cited: 1
Design, synthesis and evaluation of dihydro-1 H -indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
Shengtao Xu, Yijun Sun, Peng Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Evaluation of the oncopharmacological potentials of the novel A-ring modified 13α-estrone derivatives
H. Abu Ali
(2023)
Open Access
Page 1

Scroll to top